Delivery Order SPE2DB22D1202-SPE2DB25FVKG3
- Not listed
- The Defense Logistics Agency awarded a $3,798.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VEMLIDY 25 mg tablets (30-count units) with a completion date of July 1, 2025. This non-set-aside contract represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at $33,916.69 to AmerisourceBergen Drug Corp for VEMLIDY 25 mg tablets (30-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price contract, which is not set-aside, represents a pharmaceutical supply delivery supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order for VEMLIDY 25MG tablets (30-count packages) valued at $52,588.54 on June 18, 2025, with an ultimate completion date of July 17, 2025. This firm fixed-price, non-set-aside award represents a competitive procurement of pharmaceutical products to support federal medical needs. The contract is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,906.73 firm fixed price delivery order is for the supply of VEMLIDY 25 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VEMLIDY 25 MG TABLET UU 30S. The $4,470.24 contract has a completion date of February 23, 2024. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $4,056.24, is for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,075.64, is a Firm Fixed Price Delivery Order for the supply of VEMLIDY 25 MG TABLET medical products. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of VEMLIDY 25 MG TABLET UU 30S. The $5,716.99 firm fixed-price delivery order contract has a period of performance through February 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of VEMLIDY 25 MG TABLET medication to support military healthcare programs. The $78,612.17 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 21, 2024 with an ultimate completion date of October 22, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,708.11, is a delivery order for VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVKG3Delivery Order
The Defense Logistics Agency awarded a $6,890.00 delivery order to AmerisourceBergen Drug Corp for VEMLIDY 25 mg tablets (30-count units) on September 3, 2025, with a completion date of September 4, 2025. This firm fixed-price delivery order represents a pediatric delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's role under the DLA Troop Support Medical IDC encompasses a comprehensive portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The SPE2DX vehicle enables AmerisourceBergen to supply military healthcare programs globally, with additional customers including the Defense Health Agency and U.S. Coast Guard, demonstrating the contractor's established capacity to meet diverse federal medical supply requirements through competitive procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 9/3/25 |